Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study

The objective of the study is to investigate the relation between pretreatment depressive symptoms (DS) and the course of DS during the first year after cancer diagnosis, and overall survival among people with head and neck cancer (HNC).

[1]  Jordan H. Garst,et al.  Effect of psychosocial distress on outcome for head and neck cancer patients undergoing radiation , 2018, The Laryngoscope.

[2]  H. Kraemer,et al.  Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways , 2018, Cancer.

[3]  A. Waylen,et al.  Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from Head and Neck 5000 , 2018, Head & neck.

[4]  R. Leemans,et al.  Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal study. , 2018 .

[5]  K. Schmid,et al.  Depression and survival in head and neck cancer patients. , 2017, Oral oncology.

[6]  M. Schootman,et al.  Competing causes of death in the head and neck cancer population. , 2017, Oral oncology.

[7]  M. Gould,et al.  Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  S. Rogers,et al.  Influence of deprivation on health-related quality of life of patients with cancer of the head and neck in Merseyside and Cheshire. , 2016, The British journal of oral & maxillofacial surgery.

[9]  J. Roh,et al.  Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer , 2016, Cancer.

[10]  T. Peters,et al.  Recruitment, response rates and characteristics of 5511 people enrolled in a prospective clinical cohort study: head and neck 5000 , 2016, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[11]  A. Garden,et al.  Depression and Oropharynx Cancer Outcome , 2016, Psychosomatic medicine.

[12]  P. Cuijpers,et al.  Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer , 2016, Cancer.

[13]  M. A. O. Ignacio,et al.  How to cite this article , 2016 .

[14]  T. Peters,et al.  Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000 , 2014, BMC Cancer.

[15]  S. Ebrahim,et al.  Sun exposure and longevity: a blunder involving immortal time. , 2014, International journal of epidemiology.

[16]  Pim Cuijpers,et al.  Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. , 2014, The American journal of psychiatry.

[17]  P. Cuijpers,et al.  Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments , 2013, Psycho-oncology.

[18]  Paolo Vineis,et al.  Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. Millman,et al.  Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis , 2011, Supportive Care in Cancer.

[20]  Samy Suissa,et al.  Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes , 2010, BMJ : British Medical Journal.

[21]  M. Pinquart,et al.  Depression and cancer mortality: a meta-analysis , 2010, Psychological Medicine.

[22]  W. Linden,et al.  Depression as a predictor of disease progression and mortality in cancer patients , 2009, Cancer.

[23]  P. Cuijpers,et al.  Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. , 2009, Oral oncology.

[24]  W. Burke,et al.  Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial , 2009, Head & neck.

[25]  D. McGuire,et al.  Prevalence and correlates of depression among patients with head and neck cancer: a systematic review of implications for research. , 2009, Oncology nursing forum.

[26]  D. Ronis,et al.  Quality of life scores predict survival among patients with head and neck cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Zeev Rosberger,et al.  Psychological Distress and Cancer Survival: A Follow‐Up 10 Years After Diagnosis , 2003, Psychosomatic medicine.

[28]  G. Hordijk,et al.  Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. , 2001, European journal of cancer.

[29]  J. Ormel,et al.  A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects , 1997, Psychological Medicine.

[30]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.